Insider Trading: Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

68.50USD
31 Mar 2015
Change (% chg)

$-0.26 (-0.38%)
Prev Close
$68.76
Open
$68.48
Day's High
$68.81
Day's Low
$68.32
Volume
949,705
Avg. Vol
837,950
52-wk High
$77.30
52-wk Low
$65.95

Search Stocks
HOMBACH ROBERT J Options Exercised: 0
Trade Date: Sunday, 21 Jul 2013 Price: 53.80
Title: Chief Financial Officer Shares Held: 14,676
Type Traded: Direct Net Change in Shares This Filing: 0

Institutional Holders

% Shares Owned: 82.03%
# of Holders: 1,345
Total Shares Held: 445,855,583
3 Mo. Net Change: 1,828,886
# New Positions: 131
# Closed Positions: 76
# Increased Positions: 619
# Reduced Positions: 463
# Net Buyers: 156

Officers & Directors

Name Age Since Current Position

Robert Parkinson

64 2004 Chairman of the Board, Chief Executive Officer

Robert Hombach

49 2011 Chief Financial Officer, Corporate Vice President

David Scharf

47 2009 Corporate Vice President, General Counsel

Sebastian Bufalino

53 2013 Corporate Vice President, Controller

Todd Young

2013 Corporate Vice President, Treasurer

Jeanne Mason

59 2006 Corporate Vice President - Human Resources

Ludwig Hantson

52 2010 Corporate Vice President, President - BioScience

John Orloff

2014 Vice President, Global Head of Research and Development for Baxter BioScience

Peter Hellman

65 2011 Lead Independent Director

Thomas Chen

64 2012 Independent Director

Uma Chowdhry

66 2012 Independent Director

Blake Devitt

67 2005 Independent Director

John Forsyth

66 2003 Independent Director

Gail Fosler

66 2001 Independent Director

James Gavin

68 2003 Independent Director

Wayne Hockmeyer

71 2007 Independent Director

Carole Shapazian

70 2003 Independent Director

Thomas Stallkamp

68 2008 Independent Director

Kornelis Storm

73 2003 Independent Director

Albert Stroucken

67 2004 Independent Director

Mary Ladone

2012 IR Officer
Search Stocks